Society
New York Times: Experimental cancer vaccine reduces the risk of melanoma recurrence by 42%
WHAT TO KNOW
Elnashra: The New York Times reported that Merck and Moderna announced the complete results of a trial of an experimental vaccine designed to treat skin cancer…
Machine translation of an attributed source excerpt. Consult the original report to verify details. Translated from original reporting in another language.
